The online version of this article (doi:10.1186/s13054-017-1659-4) contains supplementary material, which is available to authorized users.
Multiple corticosteroids and treatment regimens have been used as adjuncts in the treatment of septic shock. Qualitative and quantitative differences exist at cellular and tissular levels between the different drugs and their patterns of delivery. The objective of this study was to elucidate any differences between the drugs and their treatment regimens regarding outcomes for corticosteroid use in adult patients with septic shock.
Network meta-analysis of the data used for the recently conducted Cochrane review was performed. Studies that included children and were designed to assess respiratory function in pneumonia and acute respiratory distress syndrome, as well as cross-over studies, were excluded. Network plots were created for each outcome, and all analyses were conducted using a frequentist approach assuming a random-effects model.
Complete data from 22 studies and partial data from 1 study were included. Network meta-analysis provided no clear evidence that any intervention or treatment regimen is better than any other across the spectrum of outcomes. There was strong evidence of differential efficacy in only one area: shock reversal. Hydrocortisone boluses and infusions were more likely than methylprednisolone boluses and placebo to result in shock reversal.
There was no clear evidence that any one corticosteroid drug or treatment regimen is more likely to be effective in reducing mortality or reducing the incidence of gastrointestinal bleeding or superinfection in septic shock. Hydrocortisone delivered as a bolus or as an infusion was more likely than placebo and methylprednisolone to result in shock reversal.
Additional file 1: Summary tables of included and excluded study characteristics [ 47– 60]. (DOCX 87 kb)
Additional file 2: Pairwise comparisons of the individual studies, NMA plots and results for those outcomes not included in the main text. (DOCX 2566 kb)13054_2017_1659_MOESM2_ESM.docx
Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–49. CrossRefPubMed
Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;12:CD002243.
Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.
White IR. Network meta-analysis. Stata J. 2015;15:951–85.
Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberc. 2013;62:167–72. CrossRef
Cooperative Study Group. The effectiveness of hydrocortisone in the management of severe infections. JAMA. 1963;183:462–5. CrossRef
Huh JW, Lim CM, Koh Y, Hong SB. Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3 days versus 7 days treatment [abstract 369]. Crit Care Med. 2006;34(12 Suppl):A101. CrossRef
Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India [abstract]. In: Proceedings of the American Thoracic Society Meeting, New York, NY, USA; 2005. p A24.
The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317:659–65. CrossRef
Venkatesh B, Mortimer RH, Couchman B, Hall J. Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study. Anaesth Intensive Care. 2005;33:201–9. PubMed
COIITSS Study Investigators. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303:341–8. CrossRef
Sabry NA, Omar EED. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm. 2011;2:73–81. CrossRef
Kenny FM, Preeyasombat C, Migeon CJ. Cortisol production rate. II. Normal infants, children, and adults. Pediatrics. 1966;37:34–42. PubMed
Russell GM, Durant C, Ataya A, Papastathi C, Bhake R, Woltersdorf W, et al. Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2014;81:289–93. CrossRef
Conway-Campbell B, Birnie M, Flynn B, Kershaw Y, Lightman S. Glucocorticoid pattern-dependent gene regulation in the rat hippocampus [abstract OC3.5]. In: Endocrine Abstracts. Vol. 38. Bristol, UK: BioScientifica; 2015. doi: 10.1530/endoabs.38.OC3.5.
Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2000;376:1339–46. CrossRef
Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock [abstract]. Crit Care Med. 1999;27 Suppl 1:33A. CrossRef
Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, et al. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:529–31. PubMed
Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, et al. The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency [in Chinese]. Zhonghua Nei Ke Za Zhi. 2012;51:599–603. PubMed
- Corticosteroids in septic shock: a systematic review and network meta-analysis
José A. López-López
Julian P. T. Higgins
Gianni D. Angelini
Stafford L. Lightman
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II